128 related articles for article (PubMed ID: 37058956)
1. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2.
Li R; Zhang Z; Huang S; Peng K; Jiang H; Shen J; Zhang B; Jiang X
Eur J Med Chem; 2023 May; 253():115320. PubMed ID: 37058956
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2.
Juang YP; Chou YT; Lin RX; Ma HH; Chao TL; Jan JT; Chang SY; Liang PH
Eur J Med Chem; 2022 May; 235():114295. PubMed ID: 35344901
[TBL] [Abstract][Full Text] [Related]
3. Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection.
Shamim K; Xu M; Hu X; Lee EM; Lu X; Huang R; Shah P; Xu X; Chen CZ; Shen M; Guo H; Chen L; Itkin Z; Eastman RT; Shinn P; Klumpp-Thomas C; Michael S; Simeonov A; Lo DC; Ming GL; Song H; Tang H; Zheng W; Huang W
Bioorg Med Chem Lett; 2021 May; 40():127906. PubMed ID: 33689873
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
Gassen NC; Papies J; Bajaj T; Emanuel J; Dethloff F; Chua RL; Trimpert J; Heinemann N; Niemeyer C; Weege F; Hönzke K; Aschman T; Heinz DE; Weckmann K; Ebert T; Zellner A; Lennarz M; Wyler E; Schroeder S; Richter A; Niemeyer D; Hoffmann K; Meyer TF; Heppner FL; Corman VM; Landthaler M; Hocke AC; Morkel M; Osterrieder N; Conrad C; Eils R; Radbruch H; Giavalisco P; Drosten C; Müller MA
Nat Commun; 2021 Jun; 12(1):3818. PubMed ID: 34155207
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide.
Wu CJ; Jan JT; Chen CM; Hsieh HP; Hwang DR; Liu HW; Liu CY; Huang HW; Chen SC; Hong CF; Lin RK; Chao YS; Hsu JT
Antimicrob Agents Chemother; 2004 Jul; 48(7):2693-6. PubMed ID: 15215127
[TBL] [Abstract][Full Text] [Related]
6. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
7. Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2).
Weiss A; Touret F; Baronti C; Gilles M; Hoen B; Nougairède A; de Lamballerie X; Sommer MOA
PLoS One; 2021; 16(12):e0260958. PubMed ID: 34855904
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment.
Wotring JW; McCarty SM; Shafiq K; Zhang CJ; Nguyen T; Meyer SR; Fursmidt R; Mirabelli C; Clasby MC; Wobus CE; O'Meara MJ; Sexton JZ
bioRxiv; 2022 Jul; ():. PubMed ID: 35860224
[TBL] [Abstract][Full Text] [Related]
9. Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2.
Wei D; Hu T; Zhang Y; Zheng W; Xue H; Shen J; Xie Y; Aisa HA
Bioorg Med Chem; 2021 Sep; 46():116364. PubMed ID: 34450570
[TBL] [Abstract][Full Text] [Related]
10. Extracts of
Ma J; Wei J; Chen G; Yan X; Sun H; Li N
Pharm Biol; 2023 Sep; 61(1):1446-1453. PubMed ID: 37675874
[TBL] [Abstract][Full Text] [Related]
11. Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target.
Qin B; Li Z; Tang K; Wang T; Xie Y; Aumonier S; Wang M; Yuan S; Cui S
Nat Commun; 2023 Jul; 14(1):3999. PubMed ID: 37414753
[TBL] [Abstract][Full Text] [Related]
12. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2
Gammeltoft KA; Zhou Y; Duarte Hernandez CR; Galli A; Offersgaard A; Costa R; Pham LV; Fahnøe U; Feng S; Scheel TKH; Ramirez S; Bukh J; Gottwein JM
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0268020. PubMed ID: 34097489
[TBL] [Abstract][Full Text] [Related]
14. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations.
Jitobaom K; Boonarkart C; Manopwisedjaroen S; Punyadee N; Borwornpinyo S; Thitithanyanont A; Avirutnan P; Auewarakul P
BMC Pharmacol Toxicol; 2022 Jun; 23(1):41. PubMed ID: 35717393
[TBL] [Abstract][Full Text] [Related]
17. Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives.
Yan K; Rawle DJ; Le TT; Suhrbier A
Virol J; 2021 Jun; 18(1):123. PubMed ID: 34107996
[TBL] [Abstract][Full Text] [Related]
18. Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.
Maestro S; Córdoba KM; Olague C; Argemi J; Ávila MA; González-Aseguinolaza G; Smerdou C; Fontanellas A
Biomed Pharmacother; 2021 May; 137():111384. PubMed ID: 33761605
[TBL] [Abstract][Full Text] [Related]
19. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
Desantis J; Mercorelli B; Celegato M; Croci F; Bazzacco A; Baroni M; Siragusa L; Cruciani G; Loregian A; Goracci L
Eur J Med Chem; 2021 Dec; 226():113814. PubMed ID: 34534839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
